Morgan Stanley Knock-Out OMV/ DE000ME2MJA1 /
24/01/2025 18:08:51 | Chg.+0.01 | Bid22:00:38 | Ask22:00:38 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.27EUR | +0.79% | - Bid Size: - |
- Ask Size: - |
OMV AG | 26.4376 EUR | 31/12/2078 | Call |
GlobeNewswire
26/03/2024
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01/2024
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center